From: Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function
% Lymphocytes
% Monocytes
% Granulocytes
PLT/WBC
Current specification
≥ 25
≥ 4
≤ 75
≤ 40
Updated specification
≥ 30
≥ 8
≤ 55
≤ 10